Salimah K, Hardianti MS, Anggorowati N, Taroeno-Hariadi KW. Co-expression of BCL2 and C-MYC as a Potential Predictive Factor of Survival in Diffuse Large B Cell Lymphoma with Rituximab-Based Chemotherapy. Asian Pac J Cancer Biol [Internet]. 2026 Jan. 7 [cited 2026 Jun. 4];11(1):23-9. Available from: http://waocp.com/journal/index.php/apjcb/article/view/2097